Abstract:Transdermal Drug Delivery Systems (TDDS) show significant advantages over other forms of drug application. Despite their clinical use for decades, these drug delivery devices have yet to reach their full potential. While polymer matrices are most commonly used as transdermal patches so far, inorganic carriers like mesoporous silica membranes offer several advantages, including chemical stability and their tunable porous system, with adjustable pore sizes, pore volumes and surface chemistries. In this study, we chemically modified high and low porosity mesoporous silica membranes by post-synthetic methods and compared the effects of different surface modifications on loading efficacies and release profiles of different pharmacologically relevant drugs with different chemical properties. Drug loading capacities and release profiles were substantially affected by pore structure and surface modifcations with strongly acidic SO 3 H groups or hydrophobic methyl groups, while weakly acidic COOH groups or nitrile groups showed little effects. SO 3 H modification of low porosity (LP) membranes led to markedly increased loading capacity and a more sustained release profile of anastrozole. The latter was also observed for xylazine, but associated with lesser drug loading. Likewise, the SO 3 H modification also slowed down the release of imiquimod or flunixin. Increasing LP membrane hydrophobicity by methyl modification essentially abolished anastrozole drug loading. In high porosity (HP) membranes, effects of chemical surface modifications were overall weaker. This led to particularly slow anastrozole or xylazine release profiles from methyl-modified membranes. Biocompatibility studies showed some cell-inhibitory effects of CN functionalization, but full biocompatibility of SO 3 H functionalized membranes as indicated by efficient cell attachment and high viability. Both parameters, pore structure and chemical surface modifcations, drug-dependently affect drug loading and release properties. Since they can be precisely fine-tuned in mesoporous silica membranes, this allows for the development of optimized TDDS providing high drug loading and the desired release profile of a given drug. Our results presented here indicate that the SO 3 H modification is particularly useful in this regard. Graphical abstract Download : Download high-res image (211KB) Download : Download full-size image

Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery

Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology

Synthesis and drug loading improvements on mesoporous SBA-15 by spray drying

Mesoporous Silica Nanoparticles with Manipulated Microstructures for Drug Delivery

Direct Surface Grafting of Mesoporous Silica Nanoparticles with Phospholipid Choline-Containing Copolymers Through Chain Transfer Free Radical Polymerization and Their Controlled Drug Delivery

Influence of pore size and surface area of mesoporous silica materilas (MCM-41 and KIT-6) on the drug loading and release

Engineering surface modification of biodegradable periodic mesoporous organosilica for adenosine loading

Structure-Property Relationship for Different Mesoporous Silica Nanoparticles and its Drug Delivery Applications: A Review

Chemical surface modification of mesoporous SiO 2 -based membranes for fine-tuning of drug loading and release properties

Silica-based mesoporous nanoparticles for controlled drug delivery

Synthesis of mesoporous silicate molecular sieves by the aerosol-assisted method for loading and release of drug

Applying I-Optimal Design for Tuning Internal Cavity of Hollow Mesoporous Silica Nanoparticles for 5-Fluorouracil Delivery: Investigating Drug-Loading/Releasing Behavior and Biocompatibility Properties

Mesoporous Silica as a Carrier for Amorphous Solid Dispersion

Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery

Controlled Release of Ibuprofen by Using Morphologically Modified Mesoporous Silica

Mesoporous Silica Particles as Drug Delivery Systems—The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes

Hydrophobic Functionalization of Mesoporous SBA-15 with Polyisoprene as a New Drug Delivery System

Synthesis of Mesoporous Silica Nanoparticles for Drug Delivery

Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect

Preparation and Evaluation of SBA-16, ZSM-5 and MCM-41 Mesoporous Silica Nanoparticles as Drug Delivery System for Carvedilol

Synthesis of ordered mesoporous silica MCM-41 with controlled morphology for potential application in controlled drug delivery systems